ClearPoint Neuro
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ClearPoint Neuro generated cash of -$13,720,000, which is more than the previous year. Cash used in financing activities reached the amount of $296,000 last year. Net change in cash is therefore -$4,475,000.
Cash Flow
| 2014 | -7.25M | -48.12K | 13.02M |
|---|---|---|---|
| 2015 | -8.63M | -76.88K | 4.87M |
| 2016 | -5.82M | -101.00K | 3.82M |
| 2017 | -5.99M | -26.75K | 11.99M |
| 2018 | -4.63M | -63.49K | -1.49M |
| 2019 | -2.84M | -160.19K | 5.60M |
| 2020 | -7.80M | -482K | 22.69M |
| 2021 | -12.69M | -168K | 46.87M |
| 2022 | -16.16M | -10.73M | 409K |
| 2023 | -13.72M | 8.94M | 296K |
CLPT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 27.61M | 54.10M | 20.09M | 5.69M | 3.10M | 9.28M | 3.31M | 5.40M | 9.24M | 3.51M |
Operating activities | ||||||||||
Net income | -22.08M | -16.43M | -14.41M | -6.78M | -5.53M | -6.16M | -7.16M | -8.06M | -8.44M | -4.52M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.45M | 777K | 692K | 553K | 250.56K | 109.43K | 116.45K | 155.70K | 211.94K | 377.26K |
Stock-based compensation expense | 6.07M | 4.12M | 2.07M | 1.09M | 799.11K | 0 | 1.24M | 959.58K | 1.68M | 880.76K |
| Deferred income tax benefit | 6.07M | 4.12M | 2.07M | 1.09M | 799.11K | 0 | 1.24M | 959.58K | 1.68M | 880.76K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.80M | -211K | 627K | -791K | 143.97K | -284.48K | -83.47K | 352.1K | -749.09K | 301.40K |
Inventories | 1.24M | -4.42M | -1.71M | -25K | -1.02M | 122.22K | -469.92K | 72.34K | 68.62K | -345.98K |
Accounts payable | -649K | 1.59M | -762K | -453K | 928.16K | -316.17K | -512.36M | 178.41M | -436.42M | -77.83M |
Cash generated by operating activities | -13.72M | -16.16M | -12.69M | -7.80M | -2.84M | -4.63M | -5.99M | -5.82M | -8.63M | -7.25M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -21.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -717K | -1.14M | -168K | -482K | -160.19K | -63.49K | -26.75K | -101.00K | -76.88K | -48.12K |
Acquisitions Net | 0 | 893K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 8.94M | -10.73M | -168K | -482K | -160.19K | -63.49K | -26.75K | -101.00K | -76.88K | -48.12K |
Financing activities | ||||||||||
Common Stock Issued | 506K | 745K | 47.47M | 376K | 7.42M | 77.5M | 11.99M | 3.83M | 4.87M | 12.88M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -210K | -336K | -599K | 0 | 0 | 0 | 0 | -4.75K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -2.83M | -2.13M | -2M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 296K | 409K | 46.87M | 22.69M | 5.60M | -1.49M | 11.99M | 3.82M | 4.87M | 13.02M |
Net Change In Cash | -4.47M | -26.49M | 34.01M | 14.40M | 2.59M | -6.18M | 5.97M | -2.09M | -3.83M | 5.72M |
Cash at end of period | 23.14M | 27.61M | 54.10M | 20.09M | 5.69M | 3.10M | 9.28M | 3.31M | 5.40M | 9.24M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |